GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » EBITDA Margin %

Diva Laboratories (ROCO:4153) EBITDA Margin % : 11.64% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Diva Laboratories's EBITDA for the three months ended in Sep. 2024 was NT$22.5 Mil. Diva Laboratories's Revenue for the three months ended in Sep. 2024 was NT$193.6 Mil. Therefore, Diva Laboratories's EBITDA margin for the quarter that ended in Sep. 2024 was 11.64%.


Diva Laboratories EBITDA Margin % Historical Data

The historical data trend for Diva Laboratories's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories EBITDA Margin % Chart

Diva Laboratories Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.34 11.86 6.33 5.94 8.21

Diva Laboratories Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.42 13.38 15.63 15.77 11.64

Competitive Comparison of Diva Laboratories's EBITDA Margin %

For the Diagnostics & Research subindustry, Diva Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diva Laboratories's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diva Laboratories's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Diva Laboratories's EBITDA Margin % falls into.



Diva Laboratories EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Diva Laboratories's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=77.939/949.204
=8.21 %

Diva Laboratories's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=22.542/193.621
=11.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diva Laboratories  (ROCO:4153) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Diva Laboratories EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Diva Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Zhongshan Road, 9F, No. 351, Sector 2, Zhonghe District, New Taipei City, TWN, 235
Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories Headlines

No Headlines